nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—pituitary gland—polycystic ovary syndrome	0.0803	0.277	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—adipose tissue—polycystic ovary syndrome	0.0799	0.276	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—female gonad—polycystic ovary syndrome	0.0669	0.231	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—endocrine gland—polycystic ovary syndrome	0.0622	0.215	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—AKR1C1—polycystic ovary syndrome	0.0605	0.0852	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—RBP4—polycystic ovary syndrome	0.0557	0.0784	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—AKR1C3—polycystic ovary syndrome	0.0466	0.0656	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—AKR1C1—polycystic ovary syndrome	0.0309	0.0435	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—RBP4—polycystic ovary syndrome	0.0284	0.04	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—AKR1C3—polycystic ovary syndrome	0.0238	0.0335	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.0168	0.0236	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.0133	0.0187	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.0133	0.0187	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.0111	0.0156	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.0105	0.0148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.0101	0.0141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NMNAT3—polycystic ovary syndrome	0.00976	0.0137	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00902	0.0127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00902	0.0127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00855	0.012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NMNAT3—polycystic ovary syndrome	0.00817	0.0115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.0078	0.011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00762	0.0107	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LPCAT2—polycystic ovary syndrome	0.00748	0.0105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SUOX—polycystic ovary syndrome	0.00748	0.0105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00738	0.0104	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ISYNA1—polycystic ovary syndrome	0.00695	0.00978	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00679	0.00956	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00634	0.00892	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00625	0.00879	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00602	0.00846	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TEAD2—polycystic ovary syndrome	0.00591	0.00831	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKR1C2—polycystic ovary syndrome	0.00591	0.00831	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00568	0.00799	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00559	0.00787	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NPB—polycystic ovary syndrome	0.00546	0.00769	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RPL37A—polycystic ovary syndrome	0.00503	0.00707	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PNPLA2—polycystic ovary syndrome	0.00495	0.00697	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00494	0.00695	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HMMR—polycystic ovary syndrome	0.00477	0.00671	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SRD5A1—polycystic ovary syndrome	0.00469	0.0066	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00456	0.00642	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00456	0.00642	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—STAR—polycystic ovary syndrome	0.00448	0.0063	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00443	0.00623	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00427	0.006	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00414	0.00583	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00403	0.00567	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HMMR—polycystic ovary syndrome	0.00399	0.00562	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00393	0.00552	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKR1C1—polycystic ovary syndrome	0.00392	0.00552	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD3B1—polycystic ovary syndrome	0.00381	0.00536	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00376	0.0053	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00366	0.00516	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF18—polycystic ovary syndrome	0.00364	0.00512	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RBP4—polycystic ovary syndrome	0.00361	0.00508	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00357	0.00502	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LHB—polycystic ovary syndrome	0.00347	0.00489	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD3B2—polycystic ovary syndrome	0.00339	0.00477	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00334	0.0047	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GAB1—polycystic ovary syndrome	0.00333	0.00468	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKR1C1—polycystic ovary syndrome	0.00329	0.00462	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NAMPT—polycystic ovary syndrome	0.00324	0.00456	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00314	0.00441	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00305	0.00429	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SULT2A1—polycystic ovary syndrome	0.00302	0.00426	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKR1C3—polycystic ovary syndrome	0.00302	0.00425	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FST—polycystic ovary syndrome	0.00297	0.00419	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TNRC6B—polycystic ovary syndrome	0.00297	0.00418	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00294	0.00413	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—RRM2—polycystic ovary syndrome	0.00293	0.00412	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LHB—polycystic ovary syndrome	0.0029	0.00408	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00284	0.00399	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—YAP1—polycystic ovary syndrome	0.00282	0.00397	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00275	0.00387	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SCT—polycystic ovary syndrome	0.00272	0.00383	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NAMPT—polycystic ovary syndrome	0.00271	0.00382	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.0027	0.00379	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP11A1—polycystic ovary syndrome	0.00268	0.00377	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00266	0.00374	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.0026	0.00365	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00255	0.00359	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TCF7L2—polycystic ovary syndrome	0.00255	0.00358	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKR1C3—polycystic ovary syndrome	0.00253	0.00356	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00253	0.00356	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A4—polycystic ovary syndrome	0.0025	0.00352	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP17A1—polycystic ovary syndrome	0.00249	0.0035	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRL—polycystic ovary syndrome	0.00239	0.00336	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00236	0.00332	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00233	0.00328	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—INSR—polycystic ovary syndrome	0.00223	0.00313	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TH—polycystic ovary syndrome	0.00216	0.00303	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00212	0.00298	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A4—polycystic ovary syndrome	0.0021	0.00295	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00208	0.00293	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PGR—polycystic ovary syndrome	0.00206	0.0029	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NCOR1—polycystic ovary syndrome	0.002	0.00282	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP19A1—polycystic ovary syndrome	0.00197	0.00277	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NRG1—polycystic ovary syndrome	0.00196	0.00276	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00192	0.0027	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00192	0.0027	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00183	0.00257	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00178	0.00251	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—polycystic ovary syndrome	0.00177	0.00249	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GNAS—polycystic ovary syndrome	0.00176	0.00248	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00169	0.00237	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IRS2—polycystic ovary syndrome	0.00168	0.00237	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOR1—polycystic ovary syndrome	0.00168	0.00236	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRL—polycystic ovary syndrome	0.00167	0.00235	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1A1—polycystic ovary syndrome	0.00159	0.00224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00159	0.00223	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—polycystic ovary syndrome	0.00148	0.00208	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00147	0.00207	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IRS1—polycystic ovary syndrome	0.00147	0.00207	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—INS—polycystic ovary syndrome	0.00141	0.00198	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.0014	0.00197	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00138	0.00194	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT2—polycystic ovary syndrome	0.00136	0.00191	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SERPINE1—polycystic ovary syndrome	0.00129	0.00182	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARG—polycystic ovary syndrome	0.0012	0.00169	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—POMC—polycystic ovary syndrome	0.00118	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00118	0.00166	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—INS—polycystic ovary syndrome	0.00118	0.00166	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEP—polycystic ovary syndrome	0.00115	0.00162	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00103	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—POMC—polycystic ovary syndrome	0.000991	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—INS—polycystic ovary syndrome	0.000985	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000953	0.00134	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000952	0.00134	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000905	0.00127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000622	0.000876	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—polycystic ovary syndrome	0.000615	0.000865	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—polycystic ovary syndrome	0.00043	0.000606	CbGpPWpGaD
